Treace Medical Concepts, Inc. (TMCI) Misses Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $42.11 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
• AI trade In focus, Iran sanctions loom - What’s moving markets
• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs